Cabot Corporation (NYSE:CBT) Receives $66.33 Consensus Target Price from Analysts

Shares of Cabot Corporation (NYSE:CBT) have received a consensus rating of “Reduce” from the five research firms that are currently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a buy rating on the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $66.3333.

Several equities research analysts have recently commented on CBT shares. JPMorgan Chase & Co. lowered their price objective on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a research note on Friday, November 28th. Mizuho lifted their price target on Cabot from $72.00 to $80.00 and gave the stock an “outperform” rating in a research report on Thursday, December 18th. UBS Group cut their price objective on Cabot from $82.00 to $65.00 and set a “neutral” rating on the stock in a report on Wednesday, November 5th. Weiss Ratings restated a “hold (c-)” rating on shares of Cabot in a research note on Monday, December 29th. Finally, Zacks Research lowered Cabot from a “hold” rating to a “strong sell” rating in a research report on Friday, November 7th.

Cabot Trading Up 0.8%

Cabot stock opened at $70.11 on Wednesday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.08 and a current ratio of 1.61. The stock has a market cap of $3.71 billion, a PE ratio of 11.67, a price-to-earnings-growth ratio of 3.64 and a beta of 0.89. The stock has a 50-day moving average of $64.66 and a two-hundred day moving average of $72.32. Cabot has a one year low of $58.33 and a one year high of $92.89.

Cabot (NYSE:CBT) last posted its quarterly earnings data on Monday, November 3rd. The specialty chemicals company reported $1.70 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.72 by ($0.02). The company had revenue of $899.00 million for the quarter, compared to analyst estimates of $967.02 million. Cabot had a net margin of 8.91% and a return on equity of 24.55%. The business’s revenue was down 10.2% compared to the same quarter last year. During the same quarter last year, the company earned $1.80 EPS. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. On average, research analysts anticipate that Cabot will post 7.57 EPS for the current fiscal year.

Cabot Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 12th. Stockholders of record on Friday, November 28th were paid a $0.45 dividend. The ex-dividend date was Friday, November 28th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.6%. Cabot’s dividend payout ratio is presently 29.95%.

Institutional Investors Weigh In On Cabot

Several hedge funds have recently added to or reduced their stakes in the business. Norges Bank acquired a new stake in Cabot during the second quarter worth about $51,710,000. AQR Capital Management LLC boosted its position in Cabot by 123.0% in the 2nd quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock worth $65,096,000 after purchasing an additional 478,702 shares in the last quarter. UBS Group AG grew its stake in shares of Cabot by 186.7% during the 3rd quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock worth $45,136,000 after purchasing an additional 386,514 shares during the period. American Century Companies Inc. increased its holdings in shares of Cabot by 11.1% during the 2nd quarter. American Century Companies Inc. now owns 1,664,728 shares of the specialty chemicals company’s stock valued at $124,855,000 after purchasing an additional 166,460 shares in the last quarter. Finally, Goldman Sachs Group Inc. lifted its stake in shares of Cabot by 32.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock valued at $36,802,000 after purchasing an additional 108,645 shares during the period. 93.18% of the stock is owned by hedge funds and other institutional investors.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.